These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1229807)

  • 1. Serum insulin, insulin antibodies and insulin requirement in the first period of insulin treatment in non-insulin resistant diabetics.
    Lev-Ran A; Ratt L; Gersht N
    Acta Diabetol Lat; 1975; 12(1):66-71. PubMed ID: 1229807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-binding antibodies in diabetic patients. Dynamic aspects of their formation.
    Penchev II; Shisheva AC; Ditzov SP; Andreev DC; Sirakov LM
    Acta Diabetol Lat; 1975; 12(5-6):296-302. PubMed ID: 1231464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IRI in insulin-treated diabetics during a 24-hour period.
    Rasmussen SM; Heding LG; Parbst E; Volund A
    Diabetologia; 1975 Apr; 11(2):151-8. PubMed ID: 1149948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of species of origin, purification levels, and formulation on insulin immunogenicity.
    Fineberg SE; Galloway JA; Fineberg NS; Goldman J
    Diabetes; 1983 Jul; 32(7):592-9. PubMed ID: 6345238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect on insulin antibodies on the effect iveness of insulin in metabolism].
    Bemm VH; Lohmann D; Thomitzek W-D ; Verlohren H-D
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(2):91-6. PubMed ID: 5173538
    [No Abstract]   [Full Text] [Related]  

  • 6. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
    Sebriakova M; Little JA
    Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin antibodies in diabetic pregnancy.
    Exon PD; Dixon K; Malins JM
    Lancet; 1974 Jul; 2(7873):126-8. PubMed ID: 4135434
    [No Abstract]   [Full Text] [Related]  

  • 8. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
    Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-insulin-antibodies.
    Andersen OO
    Acta Endocrinol Suppl (Copenh); 1976; 205():231-40. PubMed ID: 1087092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is proinsulin contamination of commercial insulin preparations responsible for the stimulation of insulin antibodies?].
    Kerp L; Steinhilber S; Kasemir H
    Klin Wochenschr; 1970 Jul; 48(14):884-5. PubMed ID: 5535446
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of serum C-peptide immunoreactivity by radioimmunoassay in insulin-dependent diabetics.
    Kumar MS; Schumacher OP; Deodhar SD
    Am J Clin Pathol; 1980 Jul; 74(1):78-82. PubMed ID: 6994486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of immune complexes in insulin-treated diabetics.
    Jayarao KS; Faulk WP; Karam JH; Grodsky GM; Forsham PH
    J Immunol Methods; 1973 Dec; 3(4):337-45. PubMed ID: 4591347
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of "fractionated" insulins on total plasma insulin binding capacity and insulin requirements in severe diabetes.
    Oakley NW
    Lancet; 1976 May; 1(7967):994-6. PubMed ID: 57444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified method for detecting anti-insulin antibodies and insulin-anti-insulin immune complexes.
    Virella G; Russell D; Laimins M; Colwell J
    Clin Chem; 1980 Aug; 26(9):1357-9. PubMed ID: 6994929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of anti-insulin antibodies by the radiochemical ethanol precipitation method.
    Fratino P; Gastaldi F
    Boll Soc Ital Biol Sper; 1976 Jul; 52(13):1004-8. PubMed ID: 1088079
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone.
    Koyama R; Nakanishi K; Kato M; Yamashita S; Kuwahara H; Katori H
    Am J Med Sci; 2005 May; 329(5):259-64. PubMed ID: 15894868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-precipitating antibodies in insulin-treated and untreated diabetic patients.
    Penchev I; Andreev D; Ditzov S
    Diabetologia; 1968 Jun; 4(3):164-6. PubMed ID: 5738355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.